Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (81-90 of 261) with videos related to

Pageof 27
Sort By:
Pragmatic and Observational Research|March 6, 2023
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European SurveyQuentin M Anstee, Kate Hallsworth, Niall Lynch, et al.
Journal of Hepatology|September 5, 2020
The times they are a-changin' (for NAFLD as well)Vlad Ratziu, Mary Rinella, Ulrich Beuers, et al.
Nature Metabolism|December 20, 2022
A researcher's guide to preclinical mouse NASH modelsSuchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver DiseaseJadine Scragg, Leah Avery, Sophie Cassidy, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regionsQuentin M Anstee, Kate Hallsworth, Niall Lynch, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|June 19, 2010
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitisQuentin M Anstee, Danilo Concas, Hiromi Kudo, et al.
Journal of Hepatology|November 27, 2012
Cardiac structure and function are altered in adults with non-alcoholic fatty liver diseaseKate Hallsworth, Kieren G Hollingsworth, Christian Thoma, et al.
Gut|June 16, 2022
Current therapies and new developments in NASHJean-François Dufour, Quentin M Anstee, Elisabetta Bugianesi, et al.
The American Journal of the Medical Sciences|October 4, 2021
Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver DiseaseJadine Scragg, Sarah J Charman, Vincent T van Hees, et al.
Pageof 27

Showing results (81-90 of 261) with videos related to

Sort By:
Pageof 27
Pragmatic and Observational Research|March 6, 2023
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European SurveyQuentin M Anstee, Kate Hallsworth, Niall Lynch, et al.
Journal of Hepatology|September 5, 2020
The times they are a-changin' (for NAFLD as well)Vlad Ratziu, Mary Rinella, Ulrich Beuers, et al.
Nature Metabolism|December 20, 2022
A researcher's guide to preclinical mouse NASH modelsSuchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver DiseaseJadine Scragg, Leah Avery, Sophie Cassidy, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regionsQuentin M Anstee, Kate Hallsworth, Niall Lynch, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|June 19, 2010
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitisQuentin M Anstee, Danilo Concas, Hiromi Kudo, et al.
Journal of Hepatology|November 27, 2012
Cardiac structure and function are altered in adults with non-alcoholic fatty liver diseaseKate Hallsworth, Kieren G Hollingsworth, Christian Thoma, et al.
Gut|June 16, 2022
Current therapies and new developments in NASHJean-François Dufour, Quentin M Anstee, Elisabetta Bugianesi, et al.
The American Journal of the Medical Sciences|October 4, 2021
Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver DiseaseJadine Scragg, Sarah J Charman, Vincent T van Hees, et al.
Pageof 27